Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of high affinity selective VIP1 receptor agonists

P Gourlet1, A Vandermeers, P Vertongen

  • 1Department of Biochemistry and Nutrition, Medical School, Université Libre de Bruxelles, Belgium.

Peptides
|January 1, 1997
PubMed
Summary

Researchers synthesized novel VIP1 receptor selective agonists derived from secretin and GRF to differentiate receptor functions. These agonists show promise for targeting specific VIP receptor subtypes, aiding in understanding their distinct biological roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2012
Same author

Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists.

Neuropharmacology·2003
Same author

Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations.

Biochemical Society transactions·2002
Same author

A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector.

Biochemical Society transactions·2002
Same author

Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation.

British journal of pharmacology·2002
Same author

Vasoactive intestinal peptide (VIP) stimulates [Ca2+]i and cyclic AMPin CHO cells expressing Galpha16.

Cell calcium·2001

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Receptor Biology

Background:

  • Vasoactive intestinal peptide (VIP) exerts biological effects via VIP1 and VIP2 receptors.
  • Differential tissue distribution of VIP receptor mRNAs suggests distinct functional roles.
  • Selective agonists are needed to investigate VIP receptor subtype-specific functions.

Purpose of the Study:

  • To synthesize and characterize selective agonists for VIP1 receptors.
  • To differentiate the roles of VIP1 and VIP2 receptors in biological processes.

Main Methods:

  • Synthesis of two novel VIP receptor agonists derived from secretin and GRF.
  • Binding affinity assays (IC50 values) for rat and human VIP1, VIP2, secretin, and PACAP receptors.
  • Adenylate cyclase activity assays to assess receptor activation and specificity.

Related Experiment Videos

Main Results:

  • Chicken secretin analog showed differential binding affinities across rat and human receptors.
  • A chimeric peptide [K15, R16, L27]VIP(1-7)/GRF(8-27) demonstrated high affinity for human VIP1 receptors.
  • Both synthesized analogs effectively stimulated adenylate cyclase activity in membranes expressing respective receptor subtypes.

Conclusions:

  • The synthesized analogs are selective VIP1 receptor agonists.
  • These selective agonists can be valuable tools for studying VIP receptor signaling pathways.
  • Further research can utilize these compounds to elucidate VIP's diverse physiological functions.